| Editor's Choice: Heart Failure | This latest recall involves the device's driveline boot cover, which “can become stiff over time” and cause problems for clinicians. There have been 33 complaints since 2017 related to the issue. This latest recall involves the device's driveline boot cover, which “can become stiff over time” and cause problems for clinicians. There have been 33 complaints since 2017 related to the issue. | |
| A new scientific statement from the American Heart Association examined the potential impact of many therapies, including fish oil supplements, lily of the valley and yoga. A new scientific statement from the American Heart Association examined the potential impact of many therapies, including fish oil supplements, lily of the valley and yoga. | |
| According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%. According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%. | |
| The Impella RP System is still associated with significant benefits, the FDA said, but there are certain high-risk patients who should no longer be eligible for treatment. The Impella RP System is still associated with significant benefits, the FDA said, but there are certain high-risk patients who should no longer be eligible for treatment. | |
| Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. | |
| Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association. Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association. | |
| The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa. The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa. | |
| |
|
| | |
|